PetVivo Holdings, Inc. (PETV)

Market Cap	36.77M
Revenue (ttm)	1.41M
Net Income (ttm)	-9.65M
Shares Out	33.58M
EPS (ttm)	-0.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,200
Average Volume	40,647
Open	1.120
Previous Close	1.138
Day's Range	1.120 - 1.122
52-Week Range	0.396 - 1.690
Beta	1.48
RSI	42.71
Earnings Date	Nov 14, 2025

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 24
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In 2024, PetVivo Holdings's revenue was $1.13 million, an increase of 16.91% compared to the previous year's $968,706. Losses were -$8.40 million, -23.33% less than in 2023.